Evidence-based role of bevacizumab in non-small cell lung cancer
- PMID: 23251009
- DOI: 10.1093/annonc/mds608
Evidence-based role of bevacizumab in non-small cell lung cancer
Comment on
-
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.Ann Oncol. 2013 Jan;24(1):20-30. doi: 10.1093/annonc/mds590. Epub 2012 Nov 23. Ann Oncol. 2013. PMID: 23180113